Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common shares	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income / (Loss)	Retained Earnings / (Deficit)
Balance, beginning of period (in shares) at Jun. 30, 2024		17,017,000
Balance, beginning of period at Jun. 30, 2024	$ 165,799	$ 2	$ (25,367)	$ 210,200	$ (7,913)	$ (11,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	16,799					16,799
Foreign currency translation adjustments	477				477
Changes in fair value of cash flow hedges	186				186
Purchase of treasury shares (in shares)		(3,890,000)
Purchase of treasury shares	(76,240)	$ (1)	(76,239)
Issuance of common shares (in shares)		55,000
Issuance of common shares	725			725
Stock-based compensation expense	1,191			1,191
Balance, end of period (in shares) at Dec. 31, 2024		13,182,000
Balance, end of period at Dec. 31, 2024	108,937	$ 1	(101,606)	212,116	(7,250)	5,676
Balance, beginning of period (in shares) at Sep. 30, 2024		16,765,000
Balance, beginning of period at Sep. 30, 2024	171,091	$ 2	(30,045)	210,872	(6,146)	(3,592)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	9,268					9,268
Foreign currency translation adjustments	(911)				(911)
Changes in fair value of cash flow hedges	(193)				(193)
Purchase of treasury shares (in shares)		(3,607,000)
Purchase of treasury shares	(71,562)	$ (1)	(71,561)
Issuance of common shares (in shares)		24,000
Issuance of common shares	343			343
Stock-based compensation expense	901			901
Balance, end of period (in shares) at Dec. 31, 2024		13,182,000
Balance, end of period at Dec. 31, 2024	$ 108,937	$ 1	(101,606)	212,116	(7,250)	5,676
Balance, beginning of period (in shares) at Jun. 30, 2025	13,357,990	13,358,000
Balance, beginning of period at Jun. 30, 2025	$ 134,309	$ 1	(103,338)	218,241	(6,336)	25,741
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	24,259					24,259
Foreign currency translation adjustments	(1,581)				(1,581)
Changes in fair value of cash flow hedges	(2,604)				(2,604)
Purchase of treasury shares (in shares)		(170,000)
Purchase of treasury shares	(5,555)		(5,555)
Issuance of common shares (in shares)		255,000
Issuance of common shares	3,416	$ 1		3,415
Shares withheld related to net share settlement of equity awards (in shares)		(3,000)
Shares withheld related to net share settlement of equity awards	(108)			(108)
Stock-based compensation expense	$ 2,379			2,379
Balance, end of period (in shares) at Dec. 31, 2025	13,440,178	13,440,000
Balance, end of period at Dec. 31, 2025	$ 154,515	$ 2	(108,893)	223,927	(10,521)	50,000
Balance, beginning of period (in shares) at Sep. 30, 2025		13,424,000
Balance, beginning of period at Sep. 30, 2025	143,625	$ 2	(106,018)	221,594	(9,736)	37,783
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	12,217					12,217
Foreign currency translation adjustments	(369)				(369)
Changes in fair value of cash flow hedges	(416)				(416)
Purchase of treasury shares (in shares)		(78,000)
Purchase of treasury shares	(2,875)		(2,875)
Issuance of common shares (in shares)		97,000
Issuance of common shares	1,003			1,003
Shares withheld related to net share settlement of equity awards (in shares)		(3,000)
Shares withheld related to net share settlement of equity awards	(108)			(108)
Stock-based compensation expense	$ 1,438			1,438
Balance, end of period (in shares) at Dec. 31, 2025	13,440,178	13,440,000
Balance, end of period at Dec. 31, 2025	$ 154,515	$ 2	$ (108,893)	$ 223,927	$ (10,521)	$ 50,000